Clrb Stock Forecast Zacks

The stock has traded between $1.02 and $1.13 so far today. Notably, analysts forecast that cellectar biosciences will.

Snapshot Research Report For Lzb

Buy or sell cellectar biosciences stock?

Clrb stock forecast zacks. So it had a cash runway of approximately 18 months from september 2020. Cellectar biosciences inc () stock market info recommendations: Clrb | complete cellectar biosciences inc.

Cellectar biosciences inc (clrb) stock is trading at $1.10 as of 11:50 am on wednesday, jul 21, an increase of $0.08, or 7.83% from the previous closing price of $1.02. This suggests a possible upside of 623.9% from the stock's current price. 343856 shares of the stock traded hands, compared to its average volume of 419678.

Analyst ratings, historical stock prices, earnings estimates & actuals. Is currently rated as a zacks rank 3 and we are expecting an inline return from the clrb shares relative to the market in the. Wall street stock market & finance report, prediction for the future:

You'll find the cresco labs share forecasts, stock quote and buy / sell signals below.according to present data cresco labs's crlbf shares and potentially its market environment have been in bearish cycle last 12 months (if exists). Volume today is below average. In a note to investors, the firm issued a new rating of buy.

On average, they anticipate cohbar's share price to reach $3.75 in the next twelve months. In the last year, its cash burn was us$13m. 4 wall street analysts that have issued a 1 year clrb price target, the average clrb price target is $5.38, with the highest clrb stock price forecast at $10.00 and the lowest clrb stock price forecast at $3.00.

Cellectar biosciences (nasdaq:clrb) posted its earnings results on sunday. Earnings for cellectar biosciences are expected to decrease in the coming year, from ($0.45) to ($0.46) per share. There are few to no technical positive signals at the moment.

Clrb updated stock price target summary. Since then, clrb stock has decreased by 59.8% and is now trading at $0.7230. The biopharmaceutical company reported ($0.10) earnings per share for the quarter, beating the thomson reuters consensus estimate of ($0.11) by $0.01, marketwatch earnings reports.

Their forecasts range from $2.50 to $6.00. You'll find the cellectar biosciences share forecasts, stock quote and buy / sell signals below.according to present data cellectar biosciences's clrb shares and potentially its market environment have been in bearish. Wall street stock market & finance report, prediction for the future:

Tenx investment & stock information. Analyst projections state that clrb is forecast to be at a low of $3.00 and a high of $10.00. 09:54pm, tuesday, 09'th nov 2021 dakota financial news.

Zacks' proprietary data indicates that cellectar biosciences, inc. Cellectar biosciences has not formally confirmed its next earnings publication date, but the company's estimated earnings date is tuesday, march 1st, 2022 based off prior year's report dates. Shares of cellectar biosciences traded down $0.00 on monday, reaching $0.84.

Get the latest tenax therapeutics, inc. The analysts previously had rating of hold. Buy or sell cresco labs stock?

According to the issued ratings of 3 analysts in the last year, the consensus rating for cellectar biosciences stock is buy based on the current 3 buy ratings for clrb. Cresco labs inc () stock market info recommendations: Simply put, stocks with a zacks rank of 1, 2, or 3, with a positive esp were shown to positively surprise 70% of the time.